ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

イスラジピン

Isradipine

HCID 3784
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
75695-93-1
標準SMILES
COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12
InChIKey
HMJIYCCIJYRONP-UHFFFAOYSA-N
分子式
C19H21N3O5
平均分子量
371.4 g/mol
単同位体質量
371.14812078

概要

Isradipine is a methyl ester, an isopropyl ester, a benzoxadiazole and a dihydropyridine.

名称と識別子

優先名称
Isradipine
IUPAC
3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
現地名
イスラジピン
英語名
Isradipine
分子式
C19H21N3O5
分子量
371.39

名称と別名

isradipine75695-93-1DynaCircLomirPrescalDynacirc CRPN 200-110IsradipinoIsradipinumPN-200-110DTXSID4023179isradipina
名称をさらに表示
(R)-4α-(ベンゾフラザン-4-イル)-1,4-ジヒドロ-2,6-ジメチル-3,5-ピリジンジカルボン酸3-イソプロピル5-メチルイスロジピン[R,(-)]-4-(ベンゾフラザン-4-イル)-1,4-ジヒドロ-2,6-ジメチル-3,5-ピリジンジカルボン酸3-メチル5-(1-メチルエチル)4-(2,1,3-ベンゾオキサジアゾール-4-イル)-1,4-ジヒドロ-2,6-ジメチルピリジン-3,5-ジカルボン酸3-イソプロピル5-メチルイスラジピン4-(ベンゾフラザン-4-イル)-1,4-ジヒドロ-2,6-ジメチル-3,5-ピリジンジカルボン酸3-イソプロピル5-メチル(4R)-4-(ベンゾフラザン-4-イル)-1,4-ジヒドロ-2,6-ジメチル-3,5-ピリジンジカルボン酸3-メチル5-(1-メチルエチル)4-(ベンゾフラザン-4-イル)-1,4-ジヒドロ-2,6-ジメチル-3,5-ピリジンジカルボン酸3-メチル5-イソプロピル(R)-4-(ベンゾフラザン-4-イル)-1,4-ジヒドロ-2,6-ジメチル-3,5-ピリジンジカルボン酸3-(1-メチルエチル)5-メチル4-(2,1,3-ベンゾオキサジアゾール-4-イル)-1,4-ジヒドロ-2,6-ジメチル-3,5-ピリジンジカルボン酸イソプロピルメチル4-(4-ベンゾフラザニル)-1,4-ジヒドロ-2,6-ジメチル-3,5-ピリジンジカルボン酸イソプロピルメチル3-メチル 5-プロパン-2-イル (4R)-4-(2,1,3-ベンゾオキサジアゾール-4-イル)-2,6-ジメチル-1,4-ジヒドロピリジン-3,5-ジカルボキシラート(-)-PN-200-110IomirPrescaCS-139EsradinRebfidenClivotenDynacrine
PN 205-033NSC-759892YO1UK1S5983,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl esterPN 2050343,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl esterDTXCID203179O5-methyl O3-propan-2-yl 4-(2,1,3-benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

物性

構造計算による物性

XLogP
4.3
極性表面積
104 Ų
水素結合供与体数
1
水素結合受容体数
8
回転可能結合数
6
重原子数
27
形式電荷
0
複雑度
685

実験および物理化学的性質

DrugsPharmaceuticals
LogP2.901
Solubility · 2 件

Practically insoluble (< 10 mg/L at 37 °C)

2.28e-01 g/L

Human Drugs · 4 件

Breast Feeding; Lactation; Antihypertensive Agents; Calcium Channel Blockers; Vasodilator Agents;

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Pharmaceuticals

Melting Point · 2 件

168-170 °C

168 - 170 °C

Physical DescriptionSolid

物理化学的性質

融点
166 · 166-1680C
沸点
501.9 · 501.9±60.0 °C(Predicted)
比重(密度)
1.249 · 1.249±0.06 g/cm3(Predicted)
貯蔵温度
2 · 2-8°C
溶解性
26 mg/mL · DMSO: ~26 mg/mL
外見
個体
酸解離定数(Pka)
2.56 · 2.56±0.70(Predicted)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H301 (98%): Toxic if swallowed [Danger Acute toxicity, oral]

P260, P264, P264+P265, P270, P273, P280, P301+P316, P305+P351+P338, P319, P321, P330, P337+P317, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 51 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 3 (98%)

毒性情報

Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Isradipine

vLess-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

安全データ

wgk
3
hs_code
2934990002
safety_code
22-24/25
ストレージクラス
11 - Combustible Solids

化学と産業

薬理情報

ATC Code · 2 件

C - Cardiovascular system

QC - Cardiovascular system

Protein Binding95%
Pharmacodynamics · 1 件

Isradipine decreases arterial smooth muscle contractility and subsequent vasoconstriction by inhibiting the influx of calcium ions through L-type calcium channels. Calcium ions entering the cell through these channels bind to calmodulin. Calcium-bound calmodulin then binds to and activates myosin light chain kinase (MLCK). Activated MLCK catalyzes the phosphorylation of the regulatory light chain subunit of myosin, a key step in muscle contraction. Signal amplification is achieved by calcium-induced calcium release from the sarcoplasmic reticulum through ryanodine receptors. Inhibition of the initial influx of calcium decreases the contractile activity of arterial smooth muscle cells and results in vasodilation. The vasodilatory effects of isradipine result in an overall decrease in blood pressure.

Mechanism of Action · 1 件

Isradipine belongs to the dihydropyridine (DHP) class of calcium channel blockers (CCBs), the most widely used class of CCBs. There are at least five different types of calcium channels in <i>Homo sapiens</i>: L-, N-, P/Q-, R- and T-type. CCBs target L-type calcium channels, the major channel in muscle cells that mediates contraction. Similar to other DHP CCBs, isradipine binds directly to inactive calcium channels stabilizing their inactive conformation. Since arterial smooth muscle depolarizations are longer in duration than cardiac muscle depolarizations, inactive channels are more prevalent in smooth muscle cells. Alternative splicing of the alpha-1 subunit of the channel gives isradipine additional arterial selectivity. At therapeutic sub-toxic concentrations, isradipine has little effect on cardiac myocytes and conduction cells.

Biological Half-Life8 hours
Metabolism/MetabolitesHepatic. Completely metabolized prior to excretion and no unchanged drug is detected in the urine.
FDA Pharmacological Classification

関連反応

4 件
反応記録を作成
HRID 1387604 の反応式
HRID 1387604反応物として
HRID 2054702 の反応式
HRID 2054702反応物として
HRID 2054703 の反応式
HRID 2054703生成物として
HRID 2054706 の反応式
HRID 2054706生成物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
75695-93-1
PubChem CID
3784
DTXSID
DTXSID4023179
ChEMBL
CHEMBL1648、CHEMBL315436、CHEMBL3211306
ChEBI
CHEBI:6073
UNII
YO1UK1S598
EC Number
630-420-5
Nikkaji
J33.142B、J356.392H、J356.393F
色
黄色
Merck
14 · 14,5240
BCS Class
2 · 2/4
安定性
2 · 購入日から2年間安定です。湿気を防ぎます。この DMSO またはエタノール溶液は、-20°C で 3 か月間保存できます。
主な用途
医薬品(低分子化合物)
InChI
InChI=1S/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9,16,20H,1-5H3
InChIKey
HMJIYCCIJYRONP-UHFFFAOYSA-N
SMILES
C1(C)NC(C)=C(C(OC(C)C)=O)C(C2C3C(C=CC=2)=NON=3)C=1C(OC)=O
CAS データベース
75695 · 75695-93-1(CAS DataBase Reference)
NISTの化学物質情報
Isradipine(75695-93-1)

化学的性質

化学的特性Yellow Solid

· 6 件

YO1UK1S598

ISRADIPINE

Mechanisms of Action [MoA] - Calcium Channel Antagonists

Established Pharmacologic Class [EPC] - Dihydropyridine Calcium Channel Blocker

Chemical Structure [CS] - Dihydropyridines

Isradipine is a Dihydropyridine Calcium Channel Blocker. The mechanism of action of isradipine is as a Calcium Channel Antagonist.

MeSH Pharmacological Classification · 3 件

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

A class of drugs that act by selective inhibition of calcium influx through cellular membranes.

Drugs used to cause dilation of the blood vessels.

Absorption, Distribution and Excretion · 2 件

Isradipine is 90%-95% absorbed and is subject to extensive first-pass metabolism, resulting in a bioavailability of about 15%-24%.

Approximately 60% to 65% of an administered dose is excreted in the urine and 25% to 30% in the feces.

Cellular LocationsMembrane
Metabolite PathwaysIsradipine Action Pathway

用途と製造

UsesUse (kg; approx.) in Germany (2009): >10
Use ClassificationPharmaceuticals
応用分野 · 3 件

説明Isradipine is a long-acting calcium blocker effective in the treatment of essential hypertension. The advantages of isradipine as compared with other dihydropyridine calcium antagonists include a "gentle" onset and fewer contraindications. It can be taken by patients with diabetes mellitus, chronic obstructive airway diseases, gout, congestive heart failure or ischemic heart disease.

使用Isradipine is a L-type calcium channel blocker, Isradipine has anti-atherosclerotic effects in animals and improves endothelium-mediated nitric oxide (NO)-dependent vasodilation in vitro. Additional studies indicate that Isradipine may provide a neuroprotective effect in a rat model of focal ischemia and that Isradipine produces a dose-dependent sparing of dopamine neuronal fibers and cell bodies.

一般的な説明Isradipine, 4-(4-benzofuranazyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylic acid methyl 1-methylethyl ester (DynaCirc), is another second-generationdihydropyridine-type channel blocker. This drug, like theother second-generation analogs, is more selective for vascularsmooth muscle than for myocardial tissue. It is effectivein the treatment of stable angina, reducing the frequencyof anginal attacks and the need to use nitroglycerin.

上流・下流製品情報

上流原料

3-オキソ酪酸イソプロピルベンゾフロキサン3-アミノクロトン酸メチル